Adalimumab Injection
Sponsors
St Vincent's Hospital Melbourne, Erasmus Medical Center, St George's, University of London, Chinese SLE Treatment And Research Group, University of Oxford
Conditions
Arthritis, RheumatoidChronic DiseaseCrohn DiseaseFrozen ShoulderHIV I InfectionHidradenitis SuppurativaInflammatory Bowel DiseasesMultiple Graft Failure
Phase 1
Phase 2
The Anti-Freaze-F Study- Anti-TNF for Treatment of Frozen Shoulder - a Feasibility Study
CompletedNCT05299242
Start: 2022-07-21End: 2023-06-12Updated: 2025-01-27
Tnf Inhibitors to Reduce Mortality in HIV-1 Infected PAtients With Tuberculosis meNIngitis
RecruitingNCT05590455
Start: 2023-04-11End: 2027-12-31Target: 130Updated: 2025-12-15
Phase 4
Cost-effectiveness of Adalimumab and Surgery vs Adalimumab in HS
NCT03221621
Start: 2018-07-31End: 2022-07-31Target: 128Updated: 2019-02-08
Stricture Definition and Treatment (STRIDENT) Drug Therapy Study
NCT03220841
Start: 2017-10-09End: 2021-09-30Updated: 2020-10-23
Biologics for Rheumatoid Arthritis Pain (BIORA-PAIN)
CompletedNCT04255134
Start: 2020-09-07End: 2022-10-26Updated: 2023-05-18
Comparison of Adalimumab and Tofacitinib in the Treatment of Active Takayasu Arteritis
RecruitingNCT05151848
Start: 2022-01-05End: 2026-01-15Target: 100Updated: 2023-07-24
The Clinical Efficacy of Immunomodulators in RA Patients
RecruitingNCT05626348
Start: 2021-12-22End: 2026-12-31Target: 400Updated: 2022-11-29
Therapeutic Drug Monitoring-baSed adalimuMab De-escalatiOn in nOn-infecTious cHronic Uveitis
Not yet recruitingNCT06390436
Start: 2026-12-01End: 2030-12-01Target: 320Updated: 2026-07-10